CB1 receptors mediate the analgesic effects of cannabinoids on colorectal distension-induced visceral pain in rodents (full – 2007)http://www.jneurosci.org/content/29/5/1554.long
Naphthalen-1-yl-(4-pentyloxynaphthalen-1-yl)methanone: a potent, orally bioavailable human CB1/CB2 dual agonist with antihyperalgesic properties and restricted central nervous system penetration (abst – 2007) http://www.ncbi.nlm.nih.gov/pubmed/17630726
Naphthalen-1-yl-(4-pentyloxynaphthalen-1-yl)methanone (SAB378), a peripherally restricted cannabinoid CB1/CB2 receptor agonist, inhibits gastrointestinal motility but has no effect on experimental colitis in mice (full – 2010) http://jpet.aspetjournals.org/content/334/3/973.long
Control of spasticity in a multiple sclerosis model using central nervous system-excluded CB1 cannabinoid receptor agonists (abst – 2013)http://www.ncbi.nlm.nih.gov/pubmed/24121462
Naphthalen-1-yl-(4-pentyloxynaphthalen-1-yl)methanone: a potent, orally bioavailable human CB1/CB2 dual agonist with antihyperalgesic properties and restricted central nervous system penetration (abst – 2007) http://www.ncbi.nlm.nih.gov/pubmed/17630726
Naphthalen-1-yl-(4-pentyloxynaphthalen-1-yl)methanone (SAB378), a peripherally restricted cannabinoid CB1/CB2 receptor agonist, inhibits gastrointestinal motility but has no effect on experimental colitis in mice (full – 2010) http://jpet.aspetjournals.org/content/334/3/973.long
Control of spasticity in a multiple sclerosis model using central nervous system-excluded CB1 cannabinoid receptor agonists (abst – 2013)http://www.ncbi.nlm.nih.gov/pubmed/24121462